Results 261 to 270 of about 70,730 (308)

[Catalase positive nature of African cultures of tuberculosis mycobacteria resistant to isoniazid and other preparations].

Zhurnal mikrobiologii, epidemiologii i immunobiologii, 1969
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

MYCOBACTERIUM TUBERCULOSIS AND OTHER MYCOBACTERIA

Chest Surgery Clinics of North America, 1999
The immunocompromised post-transplant HIV-positive patient is at increased risk for mycobacterial infection. Early diagnosis and aggressive therapy is critical to successful outcome. Surgical therapy may be required in patients who have complex mycobacterial lung disease, drug resistant tuberculosis, or mycobacterial infections other than tuberculosis.
J R, Mault, M, Pomerantz
openaire   +2 more sources

Mycobacteria Other than Mycobacterium tuberculosis: Review of Microbiologic and Clinical Aspects

Clinical Infectious Diseases, 1987
The rate of isolation of mycobacteria other than Mycobacterium tuberculosis (MOTT) has increased over the past several years; in some areas the isolation rate for Mycobacterium avium-Mycobacterium intracellulare has surpassed that for M. tuberculosis.
G L, Woods, J A, Washington
openaire   +2 more sources

Eugenol and Derivatives Activity Against Mycobacterium Tuberculosis , Nontuberculous Mycobacteria and Other Bacteria

Future Microbiology, 2019
To evaluate (i) the in vitro activity of eugenol (EUG) and three derivatives against Mycobacterium tuberculosis (Mtb), nontuberculous mycobacteria (NTM) and other bacteria, (ii) the EUG and antituberculosis drugs combinatory effect and (iii) the EUG and its derivatives cytotoxicity.Minimum inhibitory concentration of the compounds were determined by ...
Aryadne L, de Almeida, Katiany R, Caleffi-Ferracioli, Regiane B, de L Scodro, Vanessa P, Baldin, Débora C, Montaholi, Luiza F, Spricigo, Sandra S, Nakamura-Vasconcelos, Laíse A, Hegeto, Eloísa G, Sampiron, Giovana F, Costacurta, Diego A, Dos S Yamazaki, Gisele de, F Gauze, Vera Ld, Siqueira, Rosilene F, Cardoso   +13 more
openaire   +2 more sources

Immunology of M. tuberculosis and Other Mycobacteria

1994
More than 25% of the world’s population has been infected with Mycobacterium tuberculosis. Initial infection with M. tuberculosis is usually self-limited and inap-parent. It is associated with the subsequent acquisition of tuberculin skin test reactivity in vivo, blastogenic T-cell responses to mycobacterial proteins in vitro, and the coincident ...
Robert S. Wallis, Jerrold J. Ellner
openaire   +1 more source

Diagnosis of tuberculosis and other diseases caused by mycobacteria

Infection, 1997
The adequate diagnosis and treatment of tuberculosis depends on many events, including rapid pathogen detection, patient isolation, species identification, and drug susceptibility testing. Well trained staff, using state-of-the-art technology, are necessary in the mycobacteriology laboratory to produce timely results that are necessary for the patients'
openaire   +2 more sources

Radiometric selective inhibition tests for differentiation of Mycobacterium tuberculosis, Mycobacterium bovis, and other mycobacteria

Journal of Clinical Microbiology, 1985
In the context of a busy reference laboratory, radiometric selective inhibition tests were evaluated for rapid differentiation of Mycobacterium tuberculosis and Mycobacterium bovis and of the M. tuberculosis complex from other mycobacteria. p-Nitro-alpha-acetylamino-beta-hydroxypropiophenone at 5 micrograms and hydroxylamine hydrochloride at 62.5 and ...
W M, Gross, J E, Hawkins
openaire   +2 more sources

Test for differentiation of M. tuberculosis and M. bovis from other Mycobacteria

Canadian Journal of Microbiology, 1978
A test is described for selective inhibition of Mycobacterium tuberculosis and M. bovis isolates in fluid medium. The method employs ρ-nitro-α-acetyl-amino-β-hydroxy-propiophenone (NAP) as an inhibitory agent for differentiation of mammalian tuberculosis strains from other Mycobacteria.
A, Laszlo, L, Eidus
openaire   +2 more sources

In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria

International Journal of Antimicrobial Agents, 2005
This study describes the antimycobacterial activity of new quinoxaline derivatives against clinical isolates of Mycobacterium tuberculosis and other mycobacteria ( M. bovis, M. cheloneae, M. avium sub. paratuberculosis ). Isolates were collected in the Department of Biomedical Science (Sassari University).
ZANETTI S, SECHI, Leonardo Antonio, MOLICOTTI P, CANNAS S, BUA A, DERIU A, CARTA, Antonio, PAGLIETTI G.   +7 more
openaire   +4 more sources